8:30h Transfer Only You Atocha Hotel – Hospital
9:00h
–
10:00h		 INDUSTRY SIMPOSIUM: TAKEDA
Evidence-based and Targeted Treatment Decisions for Advanced Cutaneous T-cell Lymphoma
9:00h Welcome and Introduction Chalid Assaf, MD, PhD (Chair)
Helios Klinikum Krefeld
Krefeld, Germany
9:05h Targeted Treatment of CTCL:
Which Patient Groups Benefit? Chalid Assaf, MD, PhD
9:20h RWE in Targeted Treatment of
CTCL: Closing the Gap of Clinical Trials Evangelia Papadavid, MD, PhD
National and Kapodistrian University of Athens
Athens, Greece
9:35h Optimizing Treatment Strategy for
Advanced CTCL:
Case Study Analyses Pietro Quaglino, MD
University of Turin Medical School
Turin, Italy
9:50h Audience Q&A All
10:00h
–
11:00h
PROCLIPI and QUALITY OF LIFE Chair: J Scarisbrick, Y Kim, C Jonak
Prognostic Factors in Mycosis Fungoides & Sezary Syndrome: Results from the PROCLIPI Study
10:00h PROCLIPI-O-01 Prognostic Factors in Mycosis Fungoides & Sezary Syndrome: Results from the PROCLIPI Study
J Scarisbrick
Dermatology, University Hospital Birmingham, UK
10:12h PROCLIPI-O-02 What have we learnt about the treatment of advanced stage mycosis fungoides and Sezary syndrome from the PROCLIPI Study?
P Quaglino
Clinic of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy
10:24h QoL-O-01 Update on the development of EORTC/CLTF questionnaires to assess HRQOL in primary cutaneous T-cell and B-cell lymphomas: Phase I
K Molloy
Dermatology, Tallaght University Hospital, Dublin
10:36h QoL-O-02 Mogamulizumab-associated rashes may be related to improved therapeutic response in T-cell lymphomas
A Pileri
Dermatology Unit, IRCCS Policlinico di Sant’ Orsola, Bologna, Italy
10:48h QoL-O-03 Quality of life and its influencing factors in patients with primary cutaneous B-cell lymphomas
AEC Schirren
Department of Dermatology, University Medical Center Mannheim, Mannheim, Germany
11:00h Coffee Break
11:30h
–
12:30h
Oral Presentations 10.
Epidemiology and Imaging Chairs: JA Sanches, T Estrach, M Beylot-Barry
11:30h Epid-O-01 Racial and ethnic factors associated with differences in the receipt of treatments for patients with mycosis fungoides
J Brown-Korsah
Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
11:42h Epid-O-02 Lymphomatoid papulosis in pediatric population: preliminary results of a multicenter retrospective cohort study
M Blanchard
Department of Dermatology, CHUV, Lausanne, University of Lausanne, Switzerland
11:54h Img-O-01 Baseline radiographic imaging is useful in identifying risk factors for survival and lymph node progression
PB Allen
Winship Cancer Institute of Emory University, Atlanta, USA
12:06h Img-O-02 Lymph node infiltration in mycosis fungoides and Sézary syndrome: ultrasound features descriptive study
V Gonzalez
Radiology Department, Hospital 12 de Octubre, Madrid, Spain
12:18h LateBr-O-01 CD8+T lymphocytes in hypopigmented mycosis fungoides malignant cells or reactive clone?
S Cao
Cutaneous Lymphoma Program, Department of Dermatology, University of Pittsburgh, Pittsburgh, PA, USA
12:30h Meeting Clousure J Scarisbrick, PL Ortiz-Romero
13:00
–
14:05
13:00h Simposio para pacientes Patient’s symposium Chair: Susan Thornton, PL Ortiz-Romero, Almudena Montejo Presentation PL Ortiz-Romero
13:05h
–
14:05h		 Taller EN VIVO. Maquillaje terapéutico. Una herramienta fundamental para restaurar la autoestima y la calidad de vida de los pacientes Therapeutic Makeup: A fundamental tool to restores self-esteem and quality of life to patients. Live Makeup
Leonor Prieto Cabezas, Scientific Director Loreal Cosmética Activa Spain Expert in corrective and therapeutic makeup
14:05 Lunch
14:25h
–
16:20h
14:25h Asociación Española de Pacientes con Linfoma Cutáneo (AELIC) Spanish Association of Patients with Cutaneous Lymphoma (AELIC)
Susana Díaz Guirado, Joaquín Díez, Almudena Montejo
14:35h Grupo Español de Linfoma Cutáneo Spanish Group of Cutaneous Lymphoma
Cristina Muniesa
14:40h Micosis fungoide y síndrome de Sézary para pacientes Mycosis fungoides and Sézary Syndrome for patients
Mercedes Morillo
14:50h Linfoma anaplástico CD30+ y Papulosis linfomatoide para pacientes Anaplastic CD30+ large cell lymphoma and lymphomatoid papulosis for patients
Daniel Falkenhain
15:00h Linfomas primarios cutáneos de células B para pacientes Primary cutaneous B-cell lymphomas for patients
Concepción Postigo
15:10h Calidad de vida de pacientes con micosis fungoide. Estudio MICADOS Quality of life of patients with mycosis fungoides. MICADOS STUDY
M Mar Onteniente
15:20h Presentación del film «Más allá de la piel» (If you want to see the video, click here)
Film presentation
Marcos Martínez. AEAL.
16:20h Cierre del simposio Close remarks & Clousure Meeting
Susan Thornton, Almudena Montejo, PL Ortiz-Romero